PRUCALOPRIDE MedTAS prucalopride (as succinate) 2 mg film-coated tablet blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

prucalopride succinate, Quantity: 2.64 mg (Equivalent: prucalopride, Qty 2 mg)

Saatavilla:

MedTAS Pty Ltd

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red; macrogol 3000; indigo carmine aluminium lake

Antoreitti:

Oral

Kpl paketissa:

28 film-coated tablets

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief. ? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation. ? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Tuoteyhteenveto:

Visual Identification: Pink, round biconvex, film coated tablets debossed with P2 on one side and no debossing on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2022-09-12